Medscape said underwriters of its recent stock offering exercised their option to buy an additional 900,000 shares of Medscape's common stock at $8 per share. Medscape priced its IPO of 6.6 million shares on Sept. 27 and trading commenced the following day. CBS Corp. bought 600,000 shares. An additional 150,000 shares were purchased by Weston Presidio Capital and Highland Capital Partners.
Copyright October 1999, Crain Communications Inc.